Your browser doesn't support javascript.
COVID-19 and immunity: quo vadis?
Miyasaka, Masayuki.
  • Miyasaka M; Immunology Frontier Research Center (IFReC), Osaka University, 3-3-1, Yamada-oka, Suita 565-0871, Japan.
Int Immunol ; 33(10): 507-513, 2021 09 25.
Article in English | MEDLINE | ID: covidwho-1575069
ABSTRACT
Understanding the precise nature and durability of protective immunity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is essential in order to gain insight into the pathophysiology of coronavirus disease 2019 (COVID-19) and to develop novel treatment strategies to this disease. Here, I succinctly summarize what is currently known and unknown about the immune response during COVID-19 and discuss whether natural infections can lead to herd immunity.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Immunity, Herd / COVID-19 / Immunity, Innate Limits: Animals / Humans Language: English Journal: Int Immunol Journal subject: Allergy and Immunology Year: 2021 Document Type: Article Affiliation country: Intimm

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Immunity, Herd / COVID-19 / Immunity, Innate Limits: Animals / Humans Language: English Journal: Int Immunol Journal subject: Allergy and Immunology Year: 2021 Document Type: Article Affiliation country: Intimm